MedTrace Logo

African Descent and Glaucoma Evaluation Study

NCT00221923 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1540

Last updated 2021-07-06

No results posted yet for this study

Summary

According to the National Eye Institute, Glaucoma affects about three million Americans. Among Blacks in the United States, open- angle glaucoma is the leading cause of irreversible visual loss. Glaucoma is four times more likely to develop in Blacks than in Whites.

This is a prospective longitudinal, multi- site observational cohort study designed to obtain visual function and optic nerve structure data on eyes of Black and White Americans. The investigators will evaluate the relationship between changes in the structure of the eye and the vision loss caused by glaucoma.This is the first study where both populations are matched for quality of care and equal access to care.

Conditions

  • Primary Open Angle Glaucoma

Sponsors & Collaborators

Principal Investigators

  • Linda M Zangwill, Ph.D. · University of California, San Diego

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2022-01-31
Completion
2022-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00221923 on ClinicalTrials.gov